Tequin (gatifloxacin) is an antibiotic typically prescribed to treat pneumonia and other infections including those of the bladder, urinary tract and sinuses and for sexually transmitted diseases. Recent studies suggest that in a certain number of people, ingesting Tequin often results in being treated in emergency departments or hospitalized for blood sugar disorders.
A settlement has been reached with the Defendants which has been approved by both the Ontario and Quebec Courts. The deadline to file a claim under the settlement was February 27, 2009. This settlement has concluded and all claims have been paid.
If you would like further information regarding this action please contact Jennifer Bald at 1-800-461-6166 ext. 2455 or e-mail Jennifer.Bald@Siskinds.com.
Click here to read full CTV News article with Charles Wright, Partner at Siskinds, acting lawyer for the Plaintiffs. Link here
 Back to Siskinds Actions
|
